Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Prostatic Neoplasms 25Neoplasms 13Carcinoma, Non-Small-Cell Lung 13Breast Neoplasms 13Colonic Neoplasms 9Uterine Cervical Neoplasms 7Lung Neoplasms 6Colorectal Neoplasms 6Urinary Bladder Neoplasms 5Melanoma 5Leukemia, Myeloid, Acute 5Carcinoma, Renal Cell 5Uterine Cervical Dysplasia 4Lymphoma, Large B-Cell, Diffuse 4Esophageal Neoplasms 4Brain Neoplasms 4Thrombocythemia, Essential 3Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Polycythemia Vera 3Papillomavirus Infections 3Oropharyngeal Neoplasms 3Neuroblastoma 3Mouth Neoplasms 3Liver Neoplasms 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Glioma 3Gallbladder Neoplasms 3Carcinoma, Hepatocellular 3

Interventions

Watchful Waiting 1Chemotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pancreatic Neuroendocrine Tumors (pNET) × Watchful Waiting × Clear all
NCT07591493 2026-05-15

ADJUPANET

Gustave Roussy, Cancer Campus, Grand Paris

Phase 3 Not yet recruiting
300 enrolled
EndocrineGastrointestinalNET

Pancreatic Neuroendocrine Tumors (pNET)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡